When retatrutide attaches to this receptor, it boosts the production of glucagon, a hormone that helps break down stored energy like fat and sugar
Scientists have long understood that these drugs act on neurons in the hindbrain, a region that helps regulate basic functions and contributes to feelings of fullness and nausea
In the Phase 2 trial, participants on retatrutide showed significant reductions in hepatic fat content, with some achieving near-complete resolution of metabolic associated steatotic liver disease
We spent months reviewing and comparing the top GLP-1 programs available in 2026, evaluating each one on medical oversight, pharmacy quality, pricing transparency, and helpful patient support
Key Differences at a Glance Receptor Comparison One of the most critical distinctions between these two peptides lies in their receptor affinity
Retatrutide is an investigational medicine being developed by Eli Lilly and Company
